Resveratrol + curcumin

1. Resveratrol + curcumin has no effect on NFKB1 in humans.

   “Postprandial variations of whole-blood PPARA and NFKB1 gene expression were not different between Res/Cur and placebo treatments.”

   Human trialafter consumption of a high-fat mealwhole blood200 mg resveratrol and 100 mg curcumin6-h

   Supplementation with Resveratrol and Curcumin Does Not Affect the Inflammatory Response to a High-Fat Meal in Older Adults with Abdominal Obesity: A Randomized, Placebo-Controlled Crossover Trial

   The Journal of nutrition·Jan 8, 2018

More on NFKB1

1. Resveratrol + curcumin decreases soluble vascular cell adhesion MOLECULE-1 in humans (incremental area under the curve -4643%, P = 0.01).

   “However, Res/Cur significantly decreased the cumulative postprandial response of sVCAM-1, compared to placebo (incremental area under the curve -4643%, P = 0.01).”

   Human trialafter consumption of a high-fat mealplasma200 mg resveratrol and 100 mg curcumin6-h

   Supplementation with Resveratrol and Curcumin Does Not Affect the Inflammatory Response to a High-Fat Meal in Older Adults with Abdominal Obesity: A Randomized, Placebo-Controlled Crossover Trial

   The Journal of nutrition·Jan 8, 2018

More on Soluble vascular cell adhesion MOLECULE-1

1. Resveratrol + curcumin has no effect on inflammation in humans (PTreatment×Time > 0.05).

   “Supplementation with Res/Cur did not modify postprandial variations in circulating inflammatory markers (C-reactive protein, IL-6, IL-8, monocyte chemoattractant protein-1) and adhesion molecules”

   Human trialafter consumption of a high-fat mealblood200 mg resveratrol and 100 mg curcumin6-h

   Supplementation with Resveratrol and Curcumin Does Not Affect the Inflammatory Response to a High-Fat Meal in Older Adults with Abdominal Obesity: A Randomized, Placebo-Controlled Crossover Trial

   The Journal of nutrition·Jan 8, 2018

More on Inflammation